Pomalidomide capsules is a prescription medicine, taken along with the medicine dexamethasone, used to treat people with multiple myeloma who: \u2022 have received at least 2 prior medicines to treat multiple myeloma, including a type of medicine known as a proteasome inhibitor and lenalidomide, and \u2022 their disease has become worse during treatment or within 60 days of finishing the last treatment.<\/p>\n
Active ingredient: pomalidomide Inactive ingredients: mannitol, pregelatinized starch, and sodium stearyl fumarate. The 1-mg capsule shell contains gelatin, titanium dioxide, FD&C blue 2, yellow iron oxide, white ink, and black ink. The 2-mg capsule shell contains gelatin, titanium dioxide, FD&C blue 2, yellow iron oxide, FD&C red 3, and white ink. The 3-mg capsule shell contains gelatin, titanium dioxide, FD&C blue 2, yellow iron oxide, and white ink. The 4-mg capsule shell contains gelatin, titanium dioxide, FD&C blue 1, FD&C blue 2, and white ink.<\/p>\n
If pomalidomide capsules are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
pomalidomide capsules is a thalidomide analogue indicated, in combination with dexamethasone, for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy<\/p>\n
Approval Date: 2013 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cpomalidomide capsules\u201d based on the information you provide.<\/p>\n
\nProprietary Name: On Request
\nActive Ingredient(s):\u00a0 pomalidomide capsules
\nDosage Forms And Strengths: Capsules: 1 mg, 2 mg, 3 mg, and 4 mg
\nCurrent indications: multiple myeloma
\nMedicine Approved By: \u2013<\/strong>\u00a0European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
\nSummary of FDA approved use on approval date:<\/strong>\u00a0Click Here
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n